Stockscreener 앱 받기
15.25
3.72%
-0.59
시간 외 거래:
15.72
0.47
+3.08%
Kestra Medical Technologies Ltd 주식(KMTS)의 최신 뉴스
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 1-Year LowHere's What Happened - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 4.9%Should You Sell? - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Hits New 52-Week LowTime to Sell? - MarketBeat
Kestra Medical: Skipping A Heartbeat (NASDAQ:KMTS) - Seeking Alpha
kestra medical appoints new board member and updates executive contracts By Investing.com - Investing.com Nigeria
kestra medical appoints new board member and updates executive contracts - Investing.com
Kestra Medical Appoints Conor Hanley to Board - TipRanks
Kestra Medical appoints Conor Hanley to board of directors - TipRanks
Kestra Medical Technologies Appoints Conor Hanley as Independent Director Effective June 4, 2025 - marketscreener.com
Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors - GlobeNewswire
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 5.6%What's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Oric Pharmaceuticals (ORIC) and Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Pfizer (PFE) - The Globe and Mail
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.50 Consensus PT from Analysts - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Optimistic Buy Rating for Kestra Medical Technologies Ltd. Driven by Strategic Expansion and Promising Financial Outlook - TipRanks
Ernst & Young LLP Names Brian Webster of Kestra Medical - GlobeNewswire
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist - The Manila Times
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of ... - Eagle-Tribune
Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 7.5%Should You Sell? - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Kestra Medical Technologies to Participate in Upcoming Investor Conferences - GlobeNewswire
Digital Health Leader Kestra Medical Secures Speaking Slots at Two Major Healthcare Conferences - Stock Titan
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025 - GlobeNewswire
Brokerages Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Target Price at $27.50 - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025 - The Manila Times
Kestra Medical Technologies to Showcase Innovation in - GlobeNewswire
Kestra Medical Technologies, Ltd. to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery At Heart Rhythm 2025 - marketscreener.com
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 12-Month HighShould You Buy? - MarketBeat
The Goldman Sachs Group Has Lowered Expectations for Kestra Medical Technologies (NASDAQ:KMTS) Stock Price - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down Following Weak Earnings - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 4.3% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Posts Quarterly Earnings Results, Misses Expectations By $0.61 EPS - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss - The AM Reporter
Kestra Medical price target lowered to $23 from $24 at Goldman Sachs - TipRanks
Piper Sandler maintains $27 target on Kestra Medical stock By Investing.com - Investing.com South Africa
Piper Sandler maintains $27 target on Kestra Medical stock - Investing.com Australia
Kestra Medical Technologies revenue jumps 82% to USD 15.1M in Q3 FY25 - Medical Buyer
0.46%
0.05%
자본화:
|
볼륨(24시간):